Literature DB >> 12978241

The biological behaviour of a new synthetic anticoagulant (dextran sulphate) possessing heparin-like properties.

K W WALTON.   

Abstract

Entities:  

Keywords:  ANTICOAGULANTS

Mesh:

Substances:

Year:  1952        PMID: 12978241      PMCID: PMC1509121          DOI: 10.1111/j.1476-5381.1952.tb00705.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  6 in total

1.  The reaction of heparin with proteins and complex bases.

Authors:  L B Jaques
Journal:  Biochem J       Date:  1943-07       Impact factor: 3.857

2.  The chemistry of connective tissues. 1. The state of combination of chondroitin sulphate in cartilage.

Authors:  S M Partridge
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

3.  The chemistry of heparin.

Authors:  E Jorpes
Journal:  Biochem J       Date:  1935-08       Impact factor: 3.857

4.  Experiments with dextran sulphate as an anticoagulant.

Authors:  K WALTON
Journal:  Proc R Soc Med       Date:  1951-07

5.  Dextran sulphate--a synthetic analogue of heparin.

Authors:  C R RICKETTS
Journal:  Biochem J       Date:  1952-04       Impact factor: 3.857

6.  Interaction of dextran and fibrinogen.

Authors:  C R RICKETTS
Journal:  Nature       Date:  1952-06-07       Impact factor: 49.962

  6 in total
  20 in total

1.  Histamine release in rabbit blood by dextran and dextran sulphate.

Authors:  C G HAINING
Journal:  Br J Pharmacol Chemother       Date:  1955-03

2.  An electrophoretic investigation of interactions between bovine plasma albumin and charged dextran derivatives.

Authors:  T E THOMPSON; W M McKERNAN
Journal:  Biochem J       Date:  1961-10       Impact factor: 3.857

3.  The production of lipolytic activity in rat plasma after the intravenous injection of dextran sulphate.

Authors:  D S ROBINSON; P M HARRIS; C R RICKETTS
Journal:  Biochem J       Date:  1959-02       Impact factor: 3.857

4.  A heparin-precipitable fraction of human plasma. I. Isolation and characterization of the fraction.

Authors:  R T SMITH; R W VON KORFF
Journal:  J Clin Invest       Date:  1957-04       Impact factor: 14.808

5.  The molecular characteristics determining the anticomplementary activity of dextran sulphates.

Authors:  C E TAYLOR; K W WALTON
Journal:  Br J Exp Pathol       Date:  1957-06

6.  Alopecia following treatment with dextran sulphate and other anticoagulant drugs.

Authors:  G R TUDHOPE; H COHEN; R W MEIKLE
Journal:  Br Med J       Date:  1958-05-03

7.  In vivo and in vitro comparative assays of the anticoagulant activity of dextran sulphate and heparin.

Authors:  E GRASSET; D E SCHWARTZ
Journal:  Br J Pharmacol Chemother       Date:  1955-09

8.  Activation of rabbit serum protease by dextran sulphate.

Authors:  C G HAINING
Journal:  Br J Pharmacol Chemother       Date:  1956-06

9.  Preparation of dextran [35S] sulphate and tracer experiments in the rabbit.

Authors:  C R RICKETTS; K W WALTON; S M SADDINGTON
Journal:  Biochem J       Date:  1954-12       Impact factor: 3.857

10.  Interaction of acids of high molecular weight with albumin.

Authors:  D HAMER
Journal:  Biochem J       Date:  1954-04       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.